Transition Therapeutics

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Transition Therapeutics

Postby bromley » Fri Apr 21, 2006 2:03 pm

Dignan,

I stumbled across Transition Therapeutics (Canadian company). They have the following drug/s? in trial. Not sure if it / they are on your list?

Ian

Clinical Development

A Phase II clinical trial is underway in MS patients with data expected in the second half of calendar 2006. A Phase I clinical trial has demonstrated that EMZ701 is well-tolerated and has a good safety profile.

Creating Best-In-Class Multiple Sclerosis Product

Transition is developing MS-I.E.T. (a combination of Transition's interferon enhancer EMZ701 and interferon-beta) which has been shown to improve interferon therapy two to three-fold in MS animal models.
User avatar
bromley
Family Elder
 
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm

Advertisement

Postby dignan » Fri Apr 21, 2006 2:20 pm

Got it -- under phase II "interferon enhancing therapy"...thanks for digging though.
User avatar
dignan
Family Elder
 
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users